Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
boston blog main
boston top stories
givosiran
2
×
life sciences
national blog main
2019
activism
acute hepatic porphyria
acute hepatic porphyrias
akin akinc
aminolevulinic acid
bernie sanders
biotech
boston
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
buyout
celgene
charges
clinical trials
congress
crisis
detroit blog main
detroit top stories
drug prices
drugs
easl
fatty liver disease
fda
house of representatives
indiana blog main
indiana top stories
indivior
insulin
intercept pharmaceuticals
lawsuit
legal
liver
What
approval
2
×
drug
advanced
ago
alnylam
alnylam’s
bff
bio
conference
deals
devoted
disease
easl
fda
form
gene
indicated
interference
kicked
liver
major
medicine
nod
pharmaceuticals
quick
race
rna
rnai
roundup
second
seek
speedy
therapy
treat
updates
weeks
won’t
world's
Language
Current search:
givosiran
×
approval
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
